ArticleJournal of ovarian research2010

Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft.

Anli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.